Meningococcal Vaccines Market Size, Share, Analysis, Trends, Growth, Forecasts 2032
Meningococcal Vaccines Market Analysis By Type (Combination Vaccines, Polysaccharide Vaccines, Conjugate Vaccines, and Men B Vaccines) and By End-User (Hospital Pharmacies, Retail Pharmacies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 3.77 Billion | USD 6.32 Billion | 5.9% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Meningococcal Vaccines Market, 2016-2025 (USD Million)
- 2.2. Global Meningococcal Vaccines Market: Snapshot
- Chapter 3. Meningococcal Vaccines Market - Industry Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Rising healthcare expenditure
- 3.2.2. Changing lifestyles of females globally
- 3.3. Market restraints
- 3.3.1. Harmful reactions of drugs
- 3.3.2. High cost
- 3.4. Opportunities
- 3.4.1. Technological advancement
- 3.4.2. Increase in R&D activities
- 3.5. Porter's Five Forces Analysis
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Type
- 3.6.2. Market attractiveness analysis, by End-User
- 3.6.3. Market attractiveness analysis, by Region
- Chapter 4. Global Meningococcal Vaccines Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Meningococcal Vaccines Market: company market share, 2018
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Launch
- 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
- 4.2.4. R&D
- 4.2.5. Regional Expansion
- 4.3. Price Trend Analysis
- 4.4. Type Portfolio
- 4.5. Global Meningococcal Vaccines Market - Type Analysis
- 4.6. Global Meningococcal Vaccines Market: Type overview
- 4.6.1. Global meningococcal vaccines market share, by Type, 2018 and 2025
- 4.7. Combination Vaccines
- 4.7.1. Global Combination Vaccines Market, 2016-2025 (USD Million)
- 4.8. Polysaccharide Vaccines
- 4.8.1. Global Polysaccharide Vaccines Market, 2016-2025 (USD Million)
- 4.9. Conjugate Vaccines
- 4.9.1. Global Conjugate Vaccines Market, 2016-2025 (USD Million)
- 4.10. Men B Vaccines
- 4.10.1. Global Men B Vaccines Market, 2016-2025 (USD Million)
- 4.1. Company Market Share Analysis
- Chapter 5. Global Meningococcal Vaccines Market - End-User Analysis
- 5.1. Global Meningococcal Vaccines Market: End-User overview
- 5.1.1. Global Meningococcal Vaccines Market share, by End-User, 2018 and 2025
- 5.2. Hospital Pharmacies
- 5.2.1. Global Hospital Pharmacies Market, 2016-2025 (USD Million)
- 5.3. Retail Pharmacies
- 5.3.1. Global Retail Pharmacies Market, 2016-2025 (USD Million)
- 5.4. Others
- 5.4.1. Global Others Market, 2016-2025 (USD Million)
- 5.1. Global Meningococcal Vaccines Market: End-User overview
- Chapter 6. Global Meningococcal Vaccines Market - Regional Analysis
- 6.1. Global Meningococcal Vaccines Market: Regional overview
- 6.1.1. Global Meningococcal vaccines market share, by region, 2018 and 2025
- 6.2. North America
- 6.2.1. North America Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.2.2. North America Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.2.3. The U.S.
- 6.2.3.1. The U.S. Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.2.3.2. The U.S. Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.2.4. Rest of North America
- 6.2.4.1. Rest of North America Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.2.4.2. Rest of North America Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.3. Europe
- 6.3.1. Europe Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.3.2. Europe Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.3.3. Germany
- 6.3.3.1. Germany Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.3.3.2. Germany Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.3.4. France
- 6.3.4.1. France Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.3.4.2. France Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.3.5. UK
- 6.3.5.1. UK Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.3.5.2. UK Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.3.6. Rest of Europe
- 6.3.6.1. Rest of Europe Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.3.6.2. Rest of Europe Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.4. Asia Pacific
- 6.4.1. Asia Pacific Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.4.2. Asia Pacific Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.4.3. China
- 6.4.3.1. China Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.4.3.2. China Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.4.4. Japan
- 6.4.4.1. Japan Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.4.4.2. Japan Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.4.5. India
- 6.4.5.1. India Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.4.5.2. India Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.4.6. Rest of Asia Pacific
- 6.4.6.1. Rest of Asia Pacific Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.4.6.2. Rest of Asia Pacific Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.5. Latin America
- 6.5.1. Latin America Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.5.2. Latin America Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.5.3. Brazil
- 6.5.3.1. Brazil Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.5.3.2. Brazil Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.5.4. Rest of Latin America
- 6.5.4.1. Rest of Latin America Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.5.4.2. Rest of Latin America Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.6. The Middle East and Africa
- 6.6.1. The Middle East and Africa Meningococcal vaccines market revenue, by Type, 2016-2025 (USD Million)
- 6.6.2. The Middle East and Africa Meningococcal vaccines market revenue, by End-User, 2016-2025 (USD Million)
- 6.1. Global Meningococcal Vaccines Market: Regional overview
- Chapter 7. Company Profile
- 7.1. Novartis International
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Type portfolio
- 7.1.4. Business strategy
- 7.1.5. Recent developments
- 7.2. Nuron Biotech
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Product Type portfolio
- 7.2.4. Business strategy
- 7.2.5. Recent developments
- 7.3. GlaxoSmithKline
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Product Type portfolio
- 7.3.4. Business strategy
- 7.3.5. Recent developments
- 7.4. Pfizer
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Product Type portfolio
- 7.4.4. Business strategy
- 7.4.5. Recent developments
- 7.5. Sanofi
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Product Type portfolio
- 7.5.4. Business strategy
- 7.5.5. Recent developments
- 7.6. JN-International Medical
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Product Type portfolio
- 7.6.4. Business strategy
- 7.6.5. Recent developments
- 7.7. Baxter International
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Product Type portfolio
- 7.7.4. Business strategy
- 7.7.5. Recent developments
- 7.8. Serum Institute of India
- 7.8.1. Overview
- 7.8.2. Financials
- 7.8.3. Product Type portfolio
- 7.8.4. Business strategy
- 7.8.5. Recent developments
- 7.9. Biomed
- 7.9.1. Overview
- 7.9.2. Financials
- 7.9.3. Product Type portfolio
- 7.9.4. Business strategy
- 7.9.5. Recent developments
- 7.1. Novartis International
Table Of Figures
List of Figures
1. Market Research Process
2. Market Research Methodology
3. Global meningococcal vaccines market revenue, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Meningococcal vaccines market attractiveness analysis, by Type
6. Meningococcal Vaccines Market attractiveness analysis, by End-User
7. Meningococcal Vaccines Market attractiveness analysis, by Region
8. Company market share analysis, 2018
9. Global Meningococcal vaccines market share by Type, 2018 and 2025
10. Global Combination Vaccines Market, 2016–2025 (USD Million)
11. Global Polysaccharide Vaccines Market, 2016–2025 (USD Million)
12. Global Conjugate Vaccines Market, 2016–2025 (USD Million)
13. Global Men B Vaccines Market, 2016–2025 (USD Million)
14. Global Meningococcal vaccines market share by End-User, 2018 and 2025
15. Global Hospital Pharmacies market, 2016–2025 (USD Million)
16. Global Retail Pharmacies market, 2016–2025 (USD Million)
17. Global others market, 2016–2025 (USD Million)
Table Of Tables
List of Tables
1. Meningococcal Vaccines Market: Snapshot
2. Drivers of the global Meningococcal Vaccines Market: Impact analysis
3. Restraints of the global Meningococcal Vaccines Market: Impact analysis
4. North America Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
5. North America Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
6. The U.S. Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
7. The U.S. Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
8. Rest of North America Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
9. Rest of North America Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
10. Europe Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
11. Europe Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
12. U.K. Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
13. U.K. Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
14. Germany Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
15. Germany Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
16. France Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
17. France Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
18. Rest of Europe Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
19. Rest of Europe Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
20. Asia Pacific Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
21. Asia Pacific Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
22. China Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
23. China Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
24. Japan Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
25. Japan Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
26. India Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
27. India Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
28. Rest of Asia Pacific Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
29. Rest of Asia Pacific Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
30. Latin America Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
31. Latin America Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
32. Brazil Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
33. Brazil Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
34. Rest of Latin America Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
35. Rest of Latin America Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
36. The Middle East and Africa Meningococcal vaccines market revenue, by Type, 2016–2025 (USD Million)
37. The Middle East and Africa Meningococcal vaccines market revenue, by End-User, 2016–2025 (USD Million)
Methodology
FrequentlyAsked Questions
Meningococcal vaccines protect against infections caused by meningococcal bacteria. They help prevent meningitis and bloodstream infections.
The global meningococcal vaccines market is expected to be driven by the immunization programs, disease prevention initiatives, and increasing awareness of meningococcal infections.
According to study, the global meningococcal vaccines market size was worth around USD 3.77 Billion in 2023 and is predicted to grow to around USD 6.32 Billion By 2032.
The global meningococcal vaccines market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 5.9% during the forecast period from 2024-2032.
The global meningococcal vaccines industry is projected to be challenged by Challenges include strain variability, cold-chain logistics, and complex regulatory approvals. Pricing pressure and public immunization policy dependence affect demand.
The Opportunities lie in immunization programs, outbreak prevention, and expanded age-group coverage. Public health funding and combination vaccines drive uptake will offer significant growth opportunities in the meningococcal vaccines market.
Multivalent and conjugate vaccine development; expanded immunization programs; improved cold-chain stability are the emerging trends and innovations impacting the meningococcal vaccines market.
The global meningococcal vaccines market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global meningococcal vaccines market are; Novartis International, Nuron Biotech, GlaxoSmithKline, Pfizer, Sanofi, JN-International Medical, Baxter International, Serum Institute of India, and Biomed and others.
The report explores crucial aspects of the meningococcal vaccines market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
